An Amgen executive refutes accusations that the company published misleading results of its mid-90s clinical trial testing an anemia drug.
The Scientist
Most Recent
More than half of pharmaceutical companies on Twitter use more than one handle.
Researchers find a slew of new fungal species inhabiting the human gut, and suggest a link to an inflammatory bowel disease.
Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.
How plants pass defenses to offspring through a complex molecular network
Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.
The diversity of microbes in the great outdoors may protect against inflammatory disorders.
Techniques for simpler, cheaper, and better antibody purification
A cytokine involved in suppressing the immune system may actually activate it to kill cancer cells.
A combination of antibiotics and the body’s own defensive metabolites clears bacterial infections faster than antibiotics alone.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
